Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

ClinicalTrials.gov ID: NCT00056407

Public ClinicalTrials.gov record NCT00056407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 4-year study will compare how safe and effective an oral investigational medicine is (compared to placebo) in preventing the development of prostate cancer in men that are defined by the study entrance criteria as being at an increased risk for prostate cancer. Study visits to the clinic will occur every 6 months for up to 4 years (10 clinic visits), and a prostate biopsy will be performed at 2 and 4 years of treatment.

Study identification

NCT ID
NCT00056407
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
8,231 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 75 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2003 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Sep 23, 2016

2003 – 2009

United States locations

U.S. sites
297
U.S. states
46
U.S. cities
239
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35209 —
GSK Investigational Site Homewood Alabama 35209 —
GSK Investigational Site Huntsville Alabama 35801 —
GSK Investigational Site Mobile Alabama 36608 —
GSK Investigational Site Anchorage Alaska 99508 —
GSK Investigational Site Phoenix Arizona 85014 —
GSK Investigational Site Phoenix Arizona 85023 —
GSK Investigational Site Phoenix Arizona 85032 —
GSK Investigational Site Scottsdale Arizona 85258 —
GSK Investigational Site Sun City Arizona 85375 —
GSK Investigational Site Tucson Arizona 85710 —
GSK Investigational Site Tucson Arizona 85712 —
GSK Investigational Site Little Rock Arkansas 72205 —
GSK Investigational Site Little Rock Arkansas 72211 —
GSK Investigational Site Anaheim California 92801 —
GSK Investigational Site Atherton California 94027 —
GSK Investigational Site Culver City California 90232 —
GSK Investigational Site Encino California 91316 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Irvine California 92618 —
GSK Investigational Site La Mesa California 91942 —
GSK Investigational Site Laguna Hills California 92653 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Los Angeles California 90024 —
GSK Investigational Site Los Angeles California 90033 —
GSK Investigational Site Los Angeles California 90048 —
GSK Investigational Site Los Angeles California 90059 —
GSK Investigational Site Los Angeles California 90073 —
GSK Investigational Site Mather California 95655 —
GSK Investigational Site Newport Beach California 92660 —
GSK Investigational Site Orange California 92869 —
GSK Investigational Site Pico Rivera California 90660 —
GSK Investigational Site Poway California 92064 —
GSK Investigational Site Sacramento California 95816 —
GSK Investigational Site Salinas California 93901 —
GSK Investigational Site San Bernardino California 92404 —
GSK Investigational Site San Diego California 92103-6204 —
GSK Investigational Site San Diego California 92103 —
GSK Investigational Site San Diego California 92120 —
GSK Investigational Site San Diego California 92128 —
GSK Investigational Site San Francisco California 94108 —
GSK Investigational Site San Francisco California 94121 —
GSK Investigational Site San Ramon California 94583 —
GSK Investigational Site Santa Monica California 90404 —
GSK Investigational Site Stanford California 94305 —
GSK Investigational Site Temecula California 92591 —
GSK Investigational Site Torrance California 90505 —
GSK Investigational Site Upland California 91786 —
GSK Investigational Site Van Nuys California 91405 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Westchester California 90045 —
GSK Investigational Site Aurora Colorado 80010 —
GSK Investigational Site Aurora Colorado 80012 —
GSK Investigational Site Denver Colorado 80211 —
GSK Investigational Site Denver Colorado 80220 —
GSK Investigational Site Englewood Colorado 80113 —
GSK Investigational Site Longmont Colorado 80501 —
GSK Investigational Site Hartford Connecticut 06106 —
GSK Investigational Site Middlebury Connecticut 06762 —
GSK Investigational Site New Britain Connecticut 06052 —
GSK Investigational Site Trumbull Connecticut 06611 —
GSK Investigational Site Washington D.C. District of Columbia 20307-5001 —
GSK Investigational Site Aventura Florida 33180 —
GSK Investigational Site Clearwater Florida 33756 —
GSK Investigational Site Clearwater Florida 33761 —
GSK Investigational Site Delray Beach Florida 33484 —
GSK Investigational Site Fort Myers Florida 33916 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Jacksonville Florida 32224 —
GSK Investigational Site Jacksonville Florida 32257 —
GSK Investigational Site Lake Worth Florida 33461 —
GSK Investigational Site Largo Florida 33773 —
GSK Investigational Site Longwood Florida 32750 —
GSK Investigational Site Margate Florida 33063 —
GSK Investigational Site Melbourne Florida 32901 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site New Port Richey Florida 34652 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Ocala Florida 34474 —
GSK Investigational Site Okeechobee Florida 34972 —
GSK Investigational Site Orange Park Florida 32073 —
GSK Investigational Site Orlando Florida 32803 —
GSK Investigational Site Panama City Florida 32405 —
GSK Investigational Site Plantation Florida 33317 —
GSK Investigational Site Sarasota Florida 34237 —
GSK Investigational Site South Daytona Florida 32119 —
GSK Investigational Site St. Petersburg Florida 33703 —
GSK Investigational Site Stuart Florida 34996 —
GSK Investigational Site Tallahassee Florida 32308 —
GSK Investigational Site Tamarac Florida 33321 —
GSK Investigational Site West Palm Beach Florida 33409 —
GSK Investigational Site Atlanta Georgia 30308 —
GSK Investigational Site Atlanta Georgia 30309 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Augusta Georgia 30912 —
GSK Investigational Site Fayetteville Georgia 30214 —
GSK Investigational Site Marietta Georgia 30060 —
GSK Investigational Site Roswell Georgia 30076 —
GSK Investigational Site Woodstock Georgia 30189 —
GSK Investigational Site Honolulu Hawaii 96813 —
GSK Investigational Site Coeur d'Alene Idaho 83814 —
GSK Investigational Site Chicago Illinois 60612 —
GSK Investigational Site Chicago Illinois 60616 —
GSK Investigational Site Chicago Illinois 60637 —
GSK Investigational Site Chicago Illinois 60640 —
GSK Investigational Site Galesburg Illinois 61401 —
GSK Investigational Site Kankakee Illinois 60901 —
GSK Investigational Site Maywood Illinois 60153 —
GSK Investigational Site Melrose Park Illinois 60160 —
GSK Investigational Site Niles Illinois 60714 —
GSK Investigational Site Springfield Illinois 62781 —
GSK Investigational Site Evansville Indiana 47714 —
GSK Investigational Site Fort Wayne Indiana 46825 —
GSK Investigational Site Indianapolis Indiana 46202 —
GSK Investigational Site Jeffersonville Indiana 47130 —
GSK Investigational Site Kansas City Kansas 66160 —
GSK Investigational Site Overland Park Kansas 66211 —
GSK Investigational Site Wichita Kansas 67208 —
GSK Investigational Site Lexington Kentucky 40508 —
GSK Investigational Site Covington Louisiana 70433 —
GSK Investigational Site Gretna Louisiana 70056 —
GSK Investigational Site Houma Louisiana 70360 —
GSK Investigational Site Lafayette Louisiana 70503 —
GSK Investigational Site Metairie Louisiana 70001 —
GSK Investigational Site New Orleans Louisiana 70115 —
GSK Investigational Site New Orleans Louisiana 70119 —
GSK Investigational Site New Orleans Louisiana 70121 —
GSK Investigational Site Ruston Louisiana 71270 —
GSK Investigational Site Shreveport Louisiana 71106 —
GSK Investigational Site Annapolis Maryland 21401 —
GSK Investigational Site Baltimore Maryland 21201 —
GSK Investigational Site Greenbelt Maryland 20770 —
GSK Investigational Site Owings Mills Maryland 21117 —
GSK Investigational Site Rockville Maryland 20850 —
GSK Investigational Site Towson Maryland 21204 —
GSK Investigational Site Boston Massachusetts 02115 —
GSK Investigational Site Braintree Massachusetts 02184 —
GSK Investigational Site Haverhill Massachusetts 01830 —
GSK Investigational Site Milford Massachusetts 01757 —
GSK Investigational Site Newton Massachusetts 2462 —
GSK Investigational Site Springfield Massachusetts 01107 —
GSK Investigational Site Waltham Massachusetts 02453 —
GSK Investigational Site Watertown Massachusetts 02472 —
GSK Investigational Site West Yarmouth Massachusetts 02673 —
GSK Investigational Site Wocester Massachusetts 01608 —
GSK Investigational Site Ann Arbor Michigan 48106 —
GSK Investigational Site Detroit Michigan 48202 —
GSK Investigational Site Royal Oak Michigan 48073 —
GSK Investigational Site Saint Joseph Michigan 49085 —
GSK Investigational Site Chaska Minnesota 55318 —
GSK Investigational Site Edina Minnesota 55435 —
GSK Investigational Site Minneapolis Minnesota 55404 —
GSK Investigational Site Rochester Minnesota 55905 —
GSK Investigational Site Saint Cloud Minnesota 56303 —
GSK Investigational Site Hattiesburg Mississippi 39401 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Kansas City Missouri 64114 —
GSK Investigational Site Springfield Missouri 65807 —
GSK Investigational Site St Louis Missouri 63110-2539 —
GSK Investigational Site St Louis Missouri 63136 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Billings Montana 59102 —
GSK Investigational Site Omaha Nebraska 68114 —
GSK Investigational Site Omaha Nebraska 68131 —
GSK Investigational Site Henderson Nevada 89014 —
GSK Investigational Site Las Vegas Nevada 89106 —
GSK Investigational Site Las Vegas Nevada 89148 —
GSK Investigational Site Reno Nevada 89502 —
GSK Investigational Site Reno Nevada 89511 —
GSK Investigational Site Lebanon New Hampshire 03756 —
GSK Investigational Site Edison New Jersey 08837 —
GSK Investigational Site Hackensack New Jersey 07601 —
GSK Investigational Site Lawrencevill New Jersey 08648 —
GSK Investigational Site Marlton New Jersey 08053 —
GSK Investigational Site Perth Amboy New Jersey 08861 —
GSK Investigational Site Voorhees Township New Jersey 08043 —
GSK Investigational Site West Orange New Jersey 07052 —
GSK Investigational Site Albany New York 12208 —
GSK Investigational Site Binghamton New York 13901 —
GSK Investigational Site Brooklyn New York 11234 —
GSK Investigational Site East Syracuse New York 13057 —
GSK Investigational Site Elmont New York 11003 —
GSK Investigational Site Endwell New York 13760 —
GSK Investigational Site Garden City New York 11530 —
GSK Investigational Site Great Neck New York 11021 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site New York New York 10016 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site Orchard Park New York 14127 —
GSK Investigational Site Poughkeepsie New York 12601 —
GSK Investigational Site Rochester New York 14642 —
GSK Investigational Site Staten Island New York 10304 —
GSK Investigational Site Syracuse New York 13210 —
GSK Investigational Site The Bronx New York 10467 —
GSK Investigational Site Cary North Carolina 27511 —
GSK Investigational Site Cary North Carolina 27518 —
GSK Investigational Site Chapel Hill North Carolina 27599-7600 —
GSK Investigational Site Charlotte North Carolina 28211 —
GSK Investigational Site Charlotte North Carolina 28262 —
GSK Investigational Site Charlotte, NC 28207 North Carolina 28207 —
GSK Investigational Site Concord North Carolina 28025 —
GSK Investigational Site Durham North Carolina 27710 —
GSK Investigational Site Greensboro North Carolina 27403 —
GSK Investigational Site Greenville North Carolina 27834 —
GSK Investigational Site Raleigh North Carolina 27607 —
GSK Investigational Site Raleigh North Carolina 27612 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Bismarck North Dakota 58501 —
GSK Investigational Site Cincinnati Ohio 45212 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Columbus Ohio 43214 —
GSK Investigational Site Columbus Ohio 43220 —
GSK Investigational Site Columbus Ohio 43235 —
GSK Investigational Site Elyria Ohio 44035 —
GSK Investigational Site Kettering Ohio 45429 —
GSK Investigational Site Marion Ohio 43302 —
GSK Investigational Site Zanesville Ohio 43701 —
GSK Investigational Site Oklahoma City Oklahoma 73112 —
GSK Investigational Site Poca City Oklahoma 74601 —
GSK Investigational Site Tulsa Oklahoma 74146 —
GSK Investigational Site Oregon City Oregon 97045 —
GSK Investigational Site Portland Oregon 97205 —
GSK Investigational Site Portland Oregon 97210 —
GSK Investigational Site Portland Oregon 97213 —
GSK Investigational Site Springfield Oregon 97477 —
GSK Investigational Site Bala-Cynwyd Pennsylvania 19004 —
GSK Investigational Site Bryn Mawr Pennsylvania 19010 —
GSK Investigational Site Camp Hill Pennsylvania 17011 —
GSK Investigational Site Harrisburg Pennsylvania 17110 —
GSK Investigational Site Hershey Pennsylvania 17033-0850 —
GSK Investigational Site Lancaster Pennsylvania 17601 —
GSK Investigational Site Lancaster Pennsylvania 17604 —
GSK Investigational Site Monroeville Pennsylvania 15146 —
GSK Investigational Site Newton Pennsylvania 18940 —
GSK Investigational Site Philadelphia Pennsylvania 19107 —
GSK Investigational Site Philadelphia Pennsylvania 19141 —
GSK Investigational Site Philadelphia Pennsylvania 19144 —
GSK Investigational Site Philadelphia Pennsylvania 19152 —
GSK Investigational Site Pittsburgh Pennsylvania 15215 —
GSK Investigational Site Pittsburgh Pennsylvania 15232 —
GSK Investigational Site Rosemont Pennsylvania 19010 —
GSK Investigational Site Sellersville Pennsylvania 18960 —
GSK Investigational Site State College Pennsylvania 16801 —
GSK Investigational Site Cranston Rhode Island 02920 —
GSK Investigational Site Providence Rhode Island 02904 —
GSK Investigational Site West Warwick Rhode Island 02893 —
GSK Investigational Site Charleston South Carolina 29425 —
GSK Investigational Site Greenville South Carolina 29650 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Myrtle Beach South Carolina 29572 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Fort Pierre South Dakota 57501 —
GSK Investigational Site Germantown Tennessee 38138 —
GSK Investigational Site Knoxville Tennessee 37920 —
GSK Investigational Site Memphis Tennessee 38119 —
GSK Investigational Site Nashville Tennessee 37209 —
GSK Investigational Site Nashville Tennessee 37232-2765 —
GSK Investigational Site Amarillo Texas 79106 —
GSK Investigational Site Arlington Texas 76017 —
GSK Investigational Site Austin Texas 78757 —
GSK Investigational Site Dallas Texas 75216 —
GSK Investigational Site Dallas Texas 75230 —
GSK Investigational Site Dallas Texas 75231 —
GSK Investigational Site Dallas Texas 75234 —
GSK Investigational Site Dallas Texas 75235 —
GSK Investigational Site Fort Worth Texas 76104 —
GSK Investigational Site Fort Worth Texas 76107 —
GSK Investigational Site Houston Texas 77024 —
GSK Investigational Site Houston Texas 77030 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Texarkana Texas 75503 —
GSK Investigational Site Salt Lake City Utah 84107 —
GSK Investigational Site South Burlington Vermont 05403 —
GSK Investigational Site Alexandria Virginia 22302 —
GSK Investigational Site Charlottesville Virginia 22911 —
GSK Investigational Site Fairfax Virginia 22031 —
GSK Investigational Site Harrisonburg Virginia 22801 —
GSK Investigational Site Mechanicsville Virginia 23116 —
GSK Investigational Site Norfolk Virginia 23502 —
GSK Investigational Site Richmond Virginia 23249 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Virginia Beach Virginia 23454 —
GSK Investigational Site Graham Washington 98338 —
GSK Investigational Site Seattle Washington 98101 —
GSK Investigational Site Seattle Washington 98122 —
GSK Investigational Site Seattle Washington 98133 —
GSK Investigational Site Seattle Washington 98166 —
GSK Investigational Site Seattle Washington 98195 —
GSK Investigational Site Spokane Washington 99202 —
GSK Investigational Site Tacoma Washington 98405 —
GSK Investigational Site Tacoma Washington 98431 —
GSK Investigational Site Tacoma Washington 98499 —
GSK Investigational Site Madison Wisconsin 53715 —
GSK Investigational Site Milwaukee Wisconsin 53209 —
GSK Investigational Site Milwaukee Wisconsin 53215 —
GSK Investigational Site Cheyenne Wyoming 82001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 635 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00056407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00056407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →